Ultra‐high‐performance liquid chromatography‐quadrupole‐time of flight‐mass spectrometry combined with network pharmacology for analysis of potential quality markers of three processed products of Qingpi
Journal of Separation Science · 2024
DOI: 10.1002/jssc.202300281 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Separation Science, 2024. Verfasst von Qian Zhang und 10 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, P. R. China. Hauptthemen laut MEDLINE: Liver Diseases, Drugs, Chinese Herbal. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 70 Literaturangaben. Gefördert von: National Key R&D Program of China, School-level funding Project of Postgraduate training Innovation Project in Jiangsu Province in 2022, National Key Research and Development Program of China.
Abstract (Originalsprache)
Qingpi, a well‐known traditional Chinese medicine for qi‐regulating and commonly processed into three types of pieces, has been widely used in the clinical application of liver disease for thousands of years. In this study, an ultra‐high‐performance liquid chromatography‐quadrupole‐time of flight‐mass spectrometry approach along with multivariate statistical analysis was developed to assess and characterize the differentiations of three processed products and confirm the potential quality markers of Qingpi. In addition, a systematic analysis combined with network pharmacology and molecular docking was performed to clarify the potential mechanism of Qingpi for the treatment of liver disease. As a result, 18 components were identified and an integrated network of Qingpi‐Components‐Target‐Pathway‐Liver Disease was constructed. Eight compounds were finally screened out as the potential quality markers acting on ten main targets and pathways of liver disease. Molecular docking analysis results indicated that the quality markers had a good binding activity with the targets. Overall, this work preliminarily identified the potential quality markers of three processed products of Qingpi, and predicted its targets in the prevention and treatment of liver disease, which can provide supporting information for further study of the pharmacodynamic substances and mechanisms of Qingpi.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, P. R. China.
ORCID-Profile: Qian Zhang, Rong Xue
Förderung
- National Key R&D Program of China
- School-level funding Project of Postgraduate training Innovation Project in Jiangsu Province in 2022
- National Key Research and Development Program of China
Zitieren
APA
Zhang, Q., Xu, R., Xue, R., Mei, X., Qin, Y., Shen, K., Xu, J., Su, L., Mao, C., Xie, H., & Lu, T. (2024). Ultra‐high‐performance liquid chromatography‐quadrupole‐time of flight‐mass spectrometry combined with network pharmacology for analysis of potential quality markers of three processed products of Qingpi. Journal of Separation Science. https://doi.org/10.1002/jssc.202300281
Vancouver
Zhang Q, Xu R, Xue R, Mei X, Qin Y, Shen K, et al. Ultra‐high‐performance liquid chromatography‐quadrupole‐time of flight‐mass spectrometry combined with network pharmacology for analysis of potential quality markers of three processed products of Qingpi. Journal of Separation Science. 2024. doi:10.1002/jssc.202300281
BibTeX
@article{Zhang2024,
author = {Zhang, Qian and Xu, Ruijie and Xue, Rong and Mei, Xi and Qin, Yuwen and Shen, Ke and Xu, Jinguo and Su, Lianlin and Mao, Chunqin and Xie, Hui and Lu, Tulin},
title = {Ultra‐high‐performance liquid chromatography‐quadrupole‐time of flight‐mass spectrometry combined with network pharmacology for analysis of potential quality markers of three processed products of Qingpi},
journal = {Journal of Separation Science},
year = {2024},
doi = {10.1002/jssc.202300281}
}
EUVIMED